NCT02532647View on ClinicalTrials.gov

Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Colonoscopy
Interventions
DRUG

Remimazolam

DRUG

Midazolam

DRUG

Placebo

Trial Locations (3)

33458

Jupiter Medical Center, Jupiter

51000

Indiana University Division of Gastroenterology/Hepatology, Indianapolis

71201

Delta Research Partners Inc, Monroe

Sponsors
All Listed Sponsors
collaborator

Premier Research Group plc

UNKNOWN

lead

Paion UK Ltd.

INDUSTRY